Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iris International is a leading medical technology company that specializes in automated in vitro diagnostics, specifically in the field of urinalysis and body fluid analysis. The company is renowned for its proprietary Digital Flow Morphology technology, which utilizes high-speed imaging and sophisticated software to capture and classify particles in samples, effectively automating manual microscopy. Its flagship iQ200 series of automated urine microscopy analyzers became a standard in clinical laboratories worldwide, significantly improving workflow efficiency and diagnostic consistency. In addition to its core diagnostics business, the company provided sample processing solutions through its StatSpin subsidiary. Iris International was acquired by Danaher Corporation in 2012 for approximately $338 million and was integrated into the Beckman Coulter diagnostics platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iris International.